{"product_id":"neurostimulation-technologies-and-global-markets","title":"Neurostimulation: Technologies and Global Markets","description":"\u003cp\u003eNeurostimulation: Technologies and Global Markets\u003c\/p\u003e\n\n\u003cp\u003eReport Scope:\u003c\/p\u003e\n\n\u003cp\u003eThis report provides a comprehensive study of the global market for neurostimulation technologies and devices. It provides a detailed description of the different types of neurostimulation technologies and devices (invasive and noninvasive) and their current and historical market revenues.\u003c\/p\u003e\n\n\u003cp\u003eNeurostimulation technologies and devices include spinal cord stimulation, deep brain stimulation, sacral nerve stimulation, vagus nerve stimulation, hypoglossal nerve stimulation, transcutaneous electrical nerve stimulation, transcranial magnetic stimulation and others.\u003c\/p\u003e\n\n\u003cp\u003eThis report also covers in detail the therapeutic applications of neurostimulation technologies and devices, including chronic pain, Parkinson’s disease, epilepsy, urinary and fecal incontinence, obstructive sleep apnea, essential tremor, obsessive compulsive disorder, major depressive disorder\/clinical depression and others. An in-depth analysis of the global market for neurostimulation technologies and devices includes historical data and market projections by device type, therapeutic application and region.\u003c\/p\u003e\n\n\u003cp\u003eReport Includes:\u003c\/p\u003e\n\n\u003cp\u003e51 tables\u003c\/p\u003e\n\n\u003cp\u003eAn overview of the global markets and technologies for neurostimulation\u003c\/p\u003e\n\n\u003cp\u003eEstimation of the market size and analyses of market trends, with data from 2020 to 2022, estimates for 2023 and projection of CAGR through 2028\u003c\/p\u003e\n\n\u003cp\u003eDescription of Dorsal Root Ganglion (DRG) neurostimulator system and discussion on approved indications of stimulation therapy for various diseases\u003c\/p\u003e\n\n\u003cp\u003eDetailed description of various types of stimulation such as spinal cord stimulation, transcutaneous electrical nerve stimulation, deep brain stimulation, sacral nerve stimulation, Vagus nerve stimulation, hypoglossal nerve stimulation, and transcranial magnetic stimulation; and discussion on their mode of action and advantages\u003c\/p\u003e\n\n\u003cp\u003eInformation on recent therapy improvements and new indications for use, and discussion on alternatives to traditional stimulation therapies\u003c\/p\u003e\n\n\u003cp\u003eCoverage of ongoing scientific discoveries and technological advances in neurostimulation technologies and insights into marketed and pipeline (R\u0026amp;D) products, product recalls and reimbursement policies\u003c\/p\u003e\n\n\u003cp\u003eMarket share analysis of neurostimulation devices by application, type and region, and evaluation of market size and forecast, and detailed analysis of drivers, challenges and opportunities affecting market growth\u003c\/p\u003e\n\n\u003cp\u003eMarket share analysis of the key companies of the industry and coverage of events like mergers \u0026amp; acquisitions, joint ventures, collaborations or partnerships, and other key market strategies\u003c\/p\u003e\n\n\u003cp\u003eComprehensive company profiles of major players of the industry, including Axonics Inc., Boston Scientific Corp., Medtronic PLC, Synapse Biomedical Inc. and Xavant Technology\u003c\/p\u003e\n\n\u003cp\u003eCompanies Mentioned\u003c\/p\u003e\n\n\u003cp\u003eABBOTT LABORATORIES\u003cbr\u003e\nALEVA NEUROTHERAPEUTICS SA\u003cbr\u003e\nAVERY BIOMEDICAL DEVICES INC.\u003cbr\u003e\nAXONICS INC.\u003cbr\u003e\nBIOINDUCTION LTD.\u003cbr\u003e\nBioventus LLC\u003cbr\u003e\nBIOWAVE CORP.\u003cbr\u003e\nBOSTON SCIENTIFIC CORP.\u003cbr\u003e\nBRAINSWAY LTD.\u003cbr\u003e\nCOCHLEAR AMERICAS\u003cbr\u003e\nCVRX INC.\u003cbr\u003e\nELECTROCORE INC.\u003cbr\u003e\nINSPIRE MEDICAL SYSTEMS INC.\u003cbr\u003e\nINTEGER HOLDINGS CORP.\u003cbr\u003e\nLABORIE INC.\u003cbr\u003e\nLIVANOVA PLC\u003cbr\u003e\nMAG \u0026amp; MORE GMBH\u003cbr\u003e\nMAGSTIM INC.\u003cbr\u003e\nMEDTRONIC PLC\u003cbr\u003e\nNALU MEDICAL INC.\u003cbr\u003e\nNEUROMED CONSULTING INC.\u003cbr\u003e\nNEUROMETRIX INC.\u003cbr\u003e\nNEURONETICS INC.\u003cbr\u003e\nNEUROPACE INC.\u003cbr\u003e\nNEUROSIGMA INC.\u003cbr\u003e\nNEUROVALENS LTD.\u003cbr\u003e\nNEVRO CORP.\u003cbr\u003e\nNEXSTIM PLC\u003cbr\u003e\nNYXOAH SA\u003cbr\u003e\nSOTERIX MEDICAL INC.\u003cbr\u003e\nSYNAPSE BIOMEDICAL INC.\u003cbr\u003e\nXAVANT TECHNOLOGY (PTY) LTD.\u003cbr\u003e\nZOLL MEDICAL CORP.\u003c\/p\u003e","brand":"Life Science","offers":[{"title":"September, 2023 \/ 160 Pages \/ MCW16247587","offer_id":47670703259954,"sku":null,"price":6600.0,"currency_code":"USD","in_stock":true}],"url":"https:\/\/www.hardmanwell.com\/products\/neurostimulation-technologies-and-global-markets","provider":"HARDMAN AND WELL MANAGEMENT CONSULTANCIES L.L.C","version":"1.0","type":"link"}